Patent · US Active

E. coli separatome-based protein expression and purification platform

US10066232B2 · kind B2 · utility

0Cited by
10References
19Claims
0Family size

Assignees

Inventors

Key dates

Filing dateOct 24, 2017
Grant dateSep 4, 2018
Priority date
Expiry dateOct 24, 2037

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12P21/02
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

Provided is a separatome-based peptide, polypeptide, and protein expression and purification platform based on the juxtaposition of the binding properties of host cell genomic peptides, polypeptides, and proteins with the characteristics and location of the corresponding genes on the host cell chromosome of E. coli. The separatome-based protein expression and purification platform quantitatively describes and identifies priority deletions, modifications, or inhibitions of certain gene products to increase chromatographic separation efficiency, defined as an increase in column capacity, column selectivity, or both, with emphasis on the former. Moreover, the separatome-based protein expression and purification platform provides a computerized knowledge tool that, given separatome data and a target recombinant peptide, polypeptide, or protein, intuitively suggests strategies facilitating efficient product purification. The separatome-based protein expression and purification platform is an efficient bioseparation system that intertwines host cell expression systems and chromatography.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.